Cavidi AB
Uppsala, SE· latest recorded location
Cavidi AB is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 8
- Granted in 2026 so far
- 0
- Most recent grant
- 25 Jan 2011
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Technology areas
Share of 6 documents
Recent patents
- Viral drug susceptibility testing25 Jan 2011US 7,875,422 B2
- Method of concentrating and recovering a viral enzyme activity from biological samples16 Nov 2010US 7,833,700 B2
- Method for sensitive analyte detection assays and kits therefor27 Jun 2024US 2024/0209413 A1
- Method for assessing susceptibility of a virus to treatment by measuring enzyme activity and a system therefore13 May 2021US 2021/0139947 A1
- Viral drug susceptibility testing2 Sep 2004US 2004/0170958 A1
- Method of concentrating and recovering a viral enzyme activity from biological samples5 Jun 2003US 2003/0104441 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.